AUROPHARMANSEAurobindo Pharma Limited· PharmaceuticalsMediumNeutral
Announced Mon, 30 Jun · 16:05 IST

Aurobindo Pharma Limited has informed the Exchange about General Updates

Listed Co AcquisitionStrategic Transactions View source PDF

AUROPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Aurobindo Pharma has informed the stock exchanges that its plan to acquire up to 26% stake in Swarnaakshu Solar Power Private Limited has been delayed. The investment, originally expected to be completed by June 30, 2025, will now be completed on or before September 30, 2025. The delay is due to pending state government approval for setting up a captive solar power plant. This acquisition is part of a captive solar power purchase agreement that Aurobindo had disclosed earlier in February and March 2025.

Likely market impact

Minor delay in a small, non-core strategic investment. No material impact on Aurobindo's core pharma business or financials expected, as this is a captive power arrangement rather than a core acquisition.